AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
20 3월 2024 - 5:05AM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the Bloom Burton Healthcare Conference
on Tuesday, April 16, 2024, at 7:00 a.m. Pacific Time (10:00 a.m.
Eastern Time).
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) discovers and develops antibody
medicines for indications across therapeutic areas including
cancer, metabolic and endocrine conditions, and autoimmune
disorders. AbCellera’s engine integrates technology, data science,
infrastructure, and interdisciplinary teams to solve the most
challenging antibody discovery problems. AbCellera is focused on
advancing an internal pipeline of first-in-class and best-in-class
programs and collaborating on innovative drug development programs
with partners. For more information, please visit
www.abcellera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240319507976/en/
Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774
Business Development: Murray McCutcheon, Ph.D.; bd@abcellera.com,
+1(604)559-9005 Investor Relations: Melanie Solomon;
ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
AbCellera Biologics (NASDAQ:ABCL)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
